Clinical Trials Logo
  1. Home
  2. Female Sexual Arousal Disorder
  3. NCT05685407

Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women

Female Sexual Arousal Disorder Clinical Trial

Official title:
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women

Clinical Trial Summary

Antidepressants have negative effects on genital arousal function that hinder quality of life and jeopardize medication adherence. Moderate sympathetic nervous system (SNS) activation through exercise has shown promising results for improving antidepressant-induced genital arousal dysfunction. It is feasible that caffeine - an SNS stimulant - could improve antidepressant-induced genital arousal difficulties if ingested prior to sex. The goal of the present pilot study is to examine whether the acute administration of 300mg of caffeine increases genital arousal in women experiencing antidepressant-induced genital arousal difficulties. Women will attend two counterbalanced sessions in which they ingest either 300mg caffeine or placebo. Fifteen minutes after ingestion, they will view an erotic film while their heart rate and genital sexual arousal are measured. Caffeine could serve as a low-cost, widely accessible intervention with minimal side effects if efficacy is shown.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05685407
Study type Interventional
Source University of Texas at Austin
Contact
Status Completed
Phase Phase 1
Start date January 1, 2023
Completion date April 15, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03820453 - Clinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Function in Postmenopausal Women. N/A
Completed NCT02958176 - Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder N/A
Terminated NCT00572377 - Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder Phase 1
Recruiting NCT04948151 - Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder Phase 2
Completed NCT01382719 - Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder Phase 2
Terminated NCT03682601 - Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment Phase 2
Completed NCT01803802 - Effects of Early Abuse on Adult Intimate Relationships N/A
Completed NCT00640458 - Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder Phase 2
Not yet recruiting NCT06116045 - Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder Phase 2